Publications by authors named "Sandra Inoue"

Claim this Profile
I
Immunogenicity of HLA-restricted peptide vaccine candidates delivered by self-assembling protein nanoparticle (SAPN) technology.
Maria Belmonte, Kwadwo Asamoah Kusi, Eric Kyei-Baafour, Ebenezer Addo Ofori, Peter Burkhard, Sandra Inoue

Vaccine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.
Harini Ganeshan, Jun Huang, Maria Belmonte, Arnel Belmonte, Sandra Inoue

PLoS One· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS).
Rachel U Lee, Nora L Watson, Gena L Glickman, Lindsey White, Sandra D Isidean, Sandra Inoue

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMRAS-Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS.
Martha Sedegah, Michael R Hollingdale, Harini Ganeshan, Maria Belmonte, Jun Huang, Sandra Inoue

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria.
Maria Belmonte, Harini Ganeshan, Jun Huang, Arnel Belmonte, Sandra Inoue

Vaccine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
Martha Sedegah, Chad Porter, Emilie Goguet, Harini Ganeshan, Maria Belmonte, Sandra Inoue

PLoS One· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.
Martha Sedegah, Chad Porter, Michael R Hollingdale, Harini Ganeshan, Jun Huang, Sandra Inoue

PLoS One· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
Marvin J Sklar, Santina Maiolatesi, Noelle Patterson, Martha Sedegah, Keith Limbach, Sandra Inoue

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
Bradley Hickey, Nimfa Teneza-Mora, Joanne Lumsden, Sharina Reyes, Martha Sedegah, Sandra Inoue

PLoS One· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis